Cognitive improvement of compound danshen in an Aβ25-35 peptide-induced rat model of Alzheimer’s disease

被引：0
|
作者：
Min Liu
Haibiao Guo
Chuyuan Li
Deqin Wang
Jingang Wu
Canmao Wang
Jiangping Xu
Ren-an Qin
机构：
[1] Modern Chinese Medicine Research Institute of Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Co.,Department of Pharmacology, School of Pharmaceutical Sciences
[2] Ltd.,Post Doctoral Scientific Research Center
[3] Southern Medical University,undefined
[4] Guangzhou Pharmaceutical Corporation,undefined
来源：
BMC Complementary and Alternative Medicine | / 15卷
关键词：
Alzheimer’s disease; Compound danshen; Insulin-degrading enzyme (IDE); Neprilysin (NEP);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Improvement of melatonin on learning and memory impairment induced by amyloid β-peptide 25-35 in elder rats
    Shen, YX
    Wei, W
    Yang, J
    Liu, C
    Dong, C
    Xu, SY
    ACTA PHARMACOLOGICA SINICA, 2001, 22 (09): : 797 - 803
  • [32] Alzheimer's disease amyloid beta peptide 25-35 inhibits lipid peroxidation as a result of its membrane interactions
    Waiter, MF
    Mason, PE
    Mason, RP
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 233 (03) : 760 - 764
  • [33] Cognitive dysfunctions induced by a cholinergic blockade and Aβ25-35 peptide are attenuated by salvianolic acid B
    Kim, Dong Hyun
    Park, Se Jin
    Kim, Jong Min
    Jeon, Su Jin
    Kim, Dae-Hoon
    Cho, Young-Wuk
    Son, Kun Ho
    Lee, Hyoung Jae
    Moon, Jae-Hak
    Cheong, Jae Hoon
    Ko, Kwang Ho
    Ryu, Jong Hoon
    NEUROPHARMACOLOGY, 2011, 61 (08) : 1432 - 1440
  • [34] Reversion of beta(25-35)-amyloid peptide-induced amnesia by NMDA receptor-associated glycine site agonists
    Maurice, T
    Lockhart, BP
    Su, TP
    Privat, A
    BRAIN RESEARCH, 1996, 731 (1-2) : 249 - 253
  • [35] Jiedu-Yizhi Formula Improves Cognitive Impairment in an Aβ25-35-Induced Rat Model of Alzheimer's Disease by Inhibiting Pyroptosis
    Wang, Jiale
    Zhu, Xiaoting
    Li, Yuhui
    Zhang, Pengqi
    Wang, Tianye
    Li, Mingquan
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [36] An 11-mer Synthetic Peptide Suppressing Aggregation of Aβ25-35 and Resolving Its Aggregated Form Improves Test Performance in an Aβ25-35-Induced Alzheimer's Mouse Model
    Nakamura, Rina
    Matsuda, Akira
    Higashi, Youichirou
    Hayashi, Yoshihiro
    Konishi, Motomi
    Saito, Motoaki
    Akizawa, Toshifumi
    BIOMOLECULES, 2024, 14 (10)
  • [37] Pelargonidin improves memory deficit in amyloid β25-35 rat model of Alzheimer's disease by inhibition of glial activation, cholinesterase, and oxidative stress
    Sohanaki, Hamid
    Baluchnejadmojarad, Tourandokht
    Nikbakht, Farnaz
    Roghani, Mehrdad
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 83 : 85 - 91
  • [38] IMPLICATION OF AMYLOID -β PEPTIDE-INDUCED DECREASES OF VGLUT1 EXPRESSION IN THE COGNITIVE DEFICITS OF ALZHEIMER'S DISEASE
    Solas, M.
    Rodriguez-Perdigon, M.
    Gil-Bea, F. J.
    Ramirez, M. J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 43 - 43
  • [39] Synaptic memory mechanisms:: Alzheimer's disease amyloid β-peptide-induced dysfunction
    Rowan, M. J.
    Klyubin, I.
    Wang, Q.
    Hu, N. W.
    Anwyl, R.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 1219 - 1223
  • [40] In vitro antiaggregation and deaggregation potential of Rhizophora mucronata and its bioactive compound (+)- catechin against Alzheimer's beta amyloid peptide (25-35)
    Suganthy, Natarajan
    Malar, Dicson Sheeja
    Devi, Kasi Pandima
    NEUROLOGICAL RESEARCH, 2016, 38 (12) : 1041 - 1051
12345